Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice
- PMID: 8722542
- DOI: 10.1093/jac/37.4.769
Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice
Abstract
The efficacy of doxycycline and ciprofloxacin against an experimental plague infection was assessed by comparing the median lethal dose (MLD) of Yersinia pestis in antibiotic-treated and untreated mice. The MLD of Y. pestis GB strain in untreated mice by the intra-peritoneal route was 23 cfu. If ciprofloxacin dosage (20 or 40 mg/kg twice daily) was initiated 48 h before infection, it afforded complete protection against an intra-peritoneal challenge of 5.24 x 10(7) cfu. Ciprofloxacin therapy initiated 24 h post-challenge was less protective, the MLD was raised to 2.0 x 10(5) and 2.2 x 10(5) cfu for 40 and 20 mg/kg respectively. Doxycycline dosage (40 mg/kg twice daily) initiated 48 h prior to infection raised the MLD to 1.6 x 10(4) cfu, but other prophylactic and therapeutic regimes were ineffective against challenges greater than 6.76 x 10(2) cfu. Ciprofloxacin may therefore be a useful antibiotic to consider for the treatment of plague.
Similar articles
-
[Yersinia pestis and plague - an update].Med Monatsschr Pharm. 2014 Dec;37(12):441-8; quiz 449. Med Monatsschr Pharm. 2014. PMID: 25643450 Review. German.
-
[The plague, possible bioterrorist act].Presse Med. 2003 May 17;32(17):804-7. Presse Med. 2003. PMID: 12856327 Review. French.
-
Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.J Antimicrob Chemother. 2000 Jun;45(6):813-8. doi: 10.1093/jac/45.6.813. J Antimicrob Chemother. 2000. PMID: 10837435
-
The efficacy of ciprofloxacin and doxycycline against experimental tularaemia.J Antimicrob Chemother. 1998 Apr;41(4):461-5. doi: 10.1093/jac/41.4.461. J Antimicrob Chemother. 1998. PMID: 9598777
-
Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection.J Antimicrob Chemother. 1998 Feb;41(2):301-5. doi: 10.1093/jac/41.2.301. J Antimicrob Chemother. 1998. PMID: 9533478
Cited by
-
Yersinia pseudotuberculosis doxycycline tolerance strategies include modulating expression of genes involved in cell permeability and tRNA modifications.PLoS Pathog. 2022 May 16;18(5):e1010556. doi: 10.1371/journal.ppat.1010556. eCollection 2022 May. PLoS Pathog. 2022. PMID: 35576231 Free PMC article.
-
Antibiotic Therapy of Plague: A Review.Biomolecules. 2021 May 12;11(5):724. doi: 10.3390/biom11050724. Biomolecules. 2021. PMID: 34065940 Free PMC article. Review.
-
Subpopulations of Stressed Yersinia pseudotuberculosis Preferentially Survive Doxycycline Treatment within Host Tissues.mBio. 2020 Aug 4;11(4):e00901-20. doi: 10.1128/mBio.00901-20. mBio. 2020. PMID: 32753491 Free PMC article.
-
The African Green Monkey Model of Pneumonic Plague and US Food and Drug Administration Approval of Antimicrobials Under the Animal Rule.Clin Infect Dis. 2020 May 21;70(70 Suppl 1):S51-S59. doi: 10.1093/cid/ciz1233. Clin Infect Dis. 2020. PMID: 32435803 Free PMC article.
-
Postexposure management of healthcare personnel to infectious diseases.Hosp Pract (1995). 2015;43(2):107-27. doi: 10.1080/21548331.2015.1018091. Epub 2015 Mar 1. Hosp Pract (1995). 2015. PMID: 25728206 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical